Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The peptide problem: Hype is outrunning the evidence In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few